4th Quarter - Report

ADVANCED MEDICAL TECHNOLOGY ASSN for ADVANCED MEDICAL TECHNOLOGY ASSN

Firm
Client
Income
—
Expenses
$942,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule

LobbyistCovered position, as disclosed
GREG MICHAEL CRIST —
NICK HALSTED —
SARAH KILLEEN —
JENNIFER TOMASELLO New —
AMANDA WALSH —
KIM ZIMMERMAN —

Contacted: Centers For Medicare and Medicaid Services (CMS); White House Office; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 5269 (119th), H.R. 5343 (119th), S. 1399 (119th), S. 1717 (119th), S. 2761 (119th)

Health Issues HCR

Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to FDAs third party review program Issues related to the President's Emergency Program for AIDS Relief (PEPFAR) Issues related to National Defense Authorization Act S. 2296/H.R. 3838 Issues related to FDA regulation of diagnostic tests.

LobbyistCovered position, as disclosed
GREG MICHAEL CRIST —
NICK HALSTED —
SARAH KILLEEN —
JENNIFER TOMASELLO New —
AMANDA WALSH —
KIM ZIMMERMAN —

Contacted: Treasury, Dept of; U.S. Trade Representative (USTR); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; White House Office; Food & Drug Administration (FDA); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Environmental Protection Agency (EPA); SENATE

Bills named: S. 2296 (119th), H.R. 3838 (119th), H.R. 1539 (119th)

Budget/Appropriations BUD

Issues related to appropriations and user fee funding for the Food and Drug Administration

LobbyistCovered position, as disclosed
GREG MICHAEL CRIST —
NICK HALSTED —
SARAH KILLEEN —
JENNIFER TOMASELLO New —
AMANDA WALSH —
KIM ZIMMERMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Issues related to R&D Expense Amortization Issues related to small business taxes Issues related to capital investment expensing Issues related to Qualified Small Business Stock

LobbyistCovered position, as disclosed
GREG MICHAEL CRIST —
NICK HALSTED —
SARAH KILLEEN —
JENNIFER TOMASELLO New —
AMANDA WALSH —
KIM ZIMMERMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Tariffs on medical devices United States-Mexico-Canada Agreement (USMCA) Global Trade and EU Tariffs Japan Reimbursement

LobbyistCovered position, as disclosed
GREG MICHAEL CRIST —
NICK HALSTED —
SARAH KILLEEN —
JENNIFER TOMASELLO New —
AMANDA WALSH —
KIM ZIMMERMAN —

Contacted: Food & Drug Administration (FDA); U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES; Treasury, Dept of; White House Office; Natl Security Council (NSC); Office of Management & Budget (OMB); Commerce, Dept of (DOC); State, Dept of (DOS)

Small Business SMB

Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program. Issues related to small business taxes. Issues related to Qualified Small Business Stock.

LobbyistCovered position, as disclosed
GREG MICHAEL CRIST —
NICK HALSTED —
SARAH KILLEEN —
JENNIFER TOMASELLO New —
AMANDA WALSH —
KIM ZIMMERMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.